柯泰名副教授研究團隊發表研究成果於Clinical and Translational Medicine
連結網址：https://pubmed.ncbi.nlm.nih.gov/41249858/
In summary, we identified a novel circulating skinhoming CD4+ T cell subset, CLA+ CTSW+ T cells, that may drive psoriasis relapse by persisting in circulation, exhibiting cytotoxicity, and engaging pathogenic immune cells via MIF and PGE2/EP2 signalling, promoting a proinflammatory, Th17-skewed milieu (Figure S10). These results provide potential targets for psoriasis relapse prevention.
